Description: China Chemical & Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. The company provides sexual function supplements; cardiovascular drugs, anti-lipidemia drugs, and peripheral circulation impediment relieving agents; diabetes treatment drugs, adrenocortico steroids, and weight control drugs; and anti-infection drugs, such as antibiotics, antifungal drugs, and anti-viral drugs. It also offers nutritional supplements comprising vitamins, liver toning agents, and electrolyte and calorie preparations; antipyretic, analgesic, and anti-inflammatory medicines; digestive drugs, intestinal improvement agents, and antispasmodics; cough suppressants, antihistamines, and asthma treatment agents; BPH drugs for the urinary system; hypnotic, mental stability, and antidepressant drugs; hematology/oncology drugs; and other general preparations. In addition, the company provides over the counter drugs such as vitamins, external skin care products, cold and cough medicines, anti-inflammatory analgesics, and gastrointestinal drugs; and antibacterial and disinfection medicines. Further, it manufactures animal health products, including drugs for pigs and cattle, companion animal products, poultry drugs, and feed supplements; and offers contract manufacturing services. The company was founded in 1952 and is headquartered in Taipei, Taiwan.
Home Page: www.ccpc.com.tw
No. 23, Hsiang Yang Road
Taipei,
10046
Taiwan
Phone:
886 2 2312 4200
Officers
Name | Title |
---|---|
Mr. Chih-Yung Wu | Pres & Mang. |
Chao-Lang Lin | Director of Fin. Department |
Mr. Te-Feng Chao | Director of Admin. Support Department |
Mr. Teng-Pao Lin | Chief Auditor |
Mr. Yin-Nan Sun | VP, Deputy GM & Pres of Chunghwa Yuming Healthcare Co Ltd |
Exchange: TW
Country: TW : Taiwan
Currency: New Taiwan Dollar (NT$)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Pharmaceuticals |
GIC Sub-Industry: | Pharmaceuticals |
Forward PE: | 0 |
---|---|
Trailing PE: | 15.4857 |
Price-to-Book MRQ: | 1.2042 |
Price-to-Sales TTM: | 1.1378 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 0 |